Zhu, C., Di, L., Song, W., He, N., Gao, W., Yuan, C., Cui, X., Zeng, D. (2026). Donafenib plus sintilimab combined with TACE or HAIC for unresectable hepatocellular carcinoma: A prospective single-arm phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16179